Shared on 06 Nov 25
Fair value Increased 2.21%ATZ: Continued Double-Digit Sales Gains Will Shape Near-Term Performance
Aritzia’s analyst price target has increased from approximately C$99 to C$101, as analysts cite strengthening growth prospects and resilient performance according to recent research updates. Analyst Commentary Recent updates from Street research indicate a trend of rising optimism among analysts covering Aritzia.
Shared on 23 Oct 25
Fair value Increased 3.63%Aritzia’s analyst price target has recently increased from approximately C$95.27 to C$98.73, as analysts point to ongoing optimism. This sentiment is supported by raised targets from several research firms and continued positive outlook on the company’s growth potential.
Shared on 09 Oct 25
Fair value Increased 2.04%Aritzia's analyst price target has increased notably, rising from approximately C$93.36 to C$95.27. Analysts cited sustained revenue growth and confidence in the company's digital expansion and profitability outlook as key reasons for this adjustment.
Shared on 25 Sep 25
Fair value Increased 2.70%Analysts have raised Aritzia’s price target to CA$93.36 on confidence in its strong growth prospects, resilient demand, and operational execution, despite macroeconomic challenges. Analyst Commentary Bullish analysts cite Aritzia’s strong positioning to outperform expectations, even amid challenging macroeconomic conditions.
Shared on 23 Apr 25
Fair value Decreased 5.46%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Increased 1.97%AnalystConsensusTarget has decreased shares outstanding growth rate from 0.0% to 0.0%.
Shared on 09 Apr 25
Fair value Decreased 2.78%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 0.14%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 10%AnalystConsensusTarget made no meaningful changes to valuation assumptions.

